
- Posted using BlogPress from my iPhone
I was thrilled to be asked by Sanofi's Discuss Diabetes to join in their fathers day series of blog posts. I am privileged be there with some other guys who I an happy to call friends to share a few thoughts on being a diabetes dad.Students with diabetes most typically are type 1 diabetics. That is the form of diabetes that is an autoimmune disease. They require insulin injections and management, not as the result of life styles but as a result of their bodies no longer making insulin. Injected insulin is a balancing act. Many of the daily school events from physical education to the stress of academic work can and do impact that insulin balance. Kid may need help maintaining that balance.
With two insulin dependent type 1 students, I know first hand that this is a challenge. The clarity of this legislation will make life easier for schools, parents and mostly kids.
Safety for Pennsylvania students with diabetes means making sure schools understand diabetes and create safe environments for students to learn. More than anything schools, all schools public and private need guidance on how to create that safe environment. This legislation provides even handed, wise guidance.
Often schools officials see significant problems in creating that safe environment. The bill you are considering helps create that environment in a cost effective way. It provides for schools to train adults in the school to safely respond to an emergency when a nurse is not available.
In the current time of budget constraints safe at school programs that train adults to respond can help maintain a safe learning environment in a medically, educationally and fiscally sound manner.
WEST CHESTER, PA, June 2, 2011 /PRNewswire/ — Animas Corporation announced today the receipt of CE Mark approval for Animas® Vibe™, the first and only continuous glucose monitoring (CGM)-enabled insulin pump system with Dexcom G4™ CGM technology. Animas® Vibe™ brings together the unique features of an Animas® insulin pump and the convenience of Dexcom CGM, which is the only sensor approved for up to seven days of wear. More here.
One of the key recommendations is that the buyers of personal health solutions need to understand and value interoperability, and demand it from vendors.
“The project partners share the belief that if Europe wants to reap the full benefit of personal health systems, health stakeholders must understand the benefits of interoperability, and be empowered to demand those systems from vendors”, says Veli Stroetmann, researcher at Empirica. “Only if there are buyers who demand interoperable systems, vendors will bring them to market.”
Your Diabetes May Vary
© 2007 - 2015